Tag Archives: Dr Olav Mella
Research: Endothelial dysfunction in ME/CFS
Endothelial dysfunction and vascular homestasis in ME/CFS A sub-study of the RituxME trial by Norwegian researchers found a problem in the blood vessels on the heart in a group of people with ME/CFS. Treatment with Rituximab caused a slight … Continue reading
Research: Gut symptoms in ME/CFS
Gastrointestinal symptoms in ME/CFS The RituxME study team in Bergen, Norway have turned their attention to the little studied topic of gut symptoms in ME/CFS. Key summary: Gastrointestinal symptoms are common in ME/CFS, but there is a knowledge … Continue reading
New study shows reduced ability to regulation of the cardiovascular system in patients with ME/CFS
Kavli Trust blog post on research into ME / CFS at Haukeland University: New study shows reduced ability to regulate the cardiovascular system in patients with ME / CFS, March 26, 2021 [Google translation of a Norwegian article] … Continue reading
Rituximab leads to B-cell depletion and remission in ME/CFS
Research abstract: Background: Myalgic Encephalopathy/Chronic Fatigue Syndrome (ME/CFS) is a disease of unknown etiology. We previously reported a pilot case series followed by a small, randomized, placebo-controlled phase II study, suggesting that B-cell depletion using the monoclonal anti-CD20 antibody rituximab … Continue reading
Fluge & Mella’s patent application for a CFS treatment
Excerpt from patent application: Inventors: Øystein Fluge & Olav Mella Date of publication 26 11 2014 Nitric oxide donor for the treatment of chronic fatigue syndrome. Description [0001] The present invention relates in a first aspect to a nitric oxide donor for … Continue reading
